tapentadol phosphate (active substance) - Poland

BINATTA

The medicine is intended for the treatment of severe chronic pain in adults who require opioid analgesic treatment.

Form: tablets, prolonged release

Active substance	Dosage
tapentadol phosphate	38.285 mg

BINATTA is intended for the treatment of severe chronic pain in adults for whom opioid analgesic treatment is necessary.

Form: tablets, prolonged release

Active substance	Dosage
tapentadol phosphate	76.57 mg

It is used in the treatment of severe chronic pain in adults for whom opioid medication is necessary.

Form: tablets, prolonged release

Active substance	Dosage
tapentadol phosphate	153.139 mg

The medicine is intended for the treatment of severe chronic pain in adults for whom the use of opioid medicines is necessary for proper treatment.

Form: tablets, prolonged release

Active substance	Dosage
tapentadol phosphate	229.709 mg

The medicine is used for the treatment of severe chronic pain in adults who require opioid analgesic treatment.

Form: tablets, prolonged release

Active substance	Dosage
tapentadol phosphate	306.279 mg

The medicine is intended for the treatment of severe chronic pain in adults for whom opioid medication is necessary.

Form: tablets, prolonged release

Active substance	Dosage
tapentadol phosphate	382.848 mg